| Primary |
| Asthma |
42.6% |
| Drug Use For Unknown Indication |
38.1% |
| Chronic Obstructive Pulmonary Disease |
12.8% |
| Emphysema |
1.8% |
| Bronchitis |
0.9% |
| Hypertension |
0.8% |
| Cough |
0.6% |
| Pneumonia |
0.4% |
| Depression |
0.3% |
| Multiple Allergies |
0.2% |
| Wheezing |
0.2% |
| Prophylaxis |
0.2% |
| Ill-defined Disorder |
0.2% |
| Product Used For Unknown Indication |
0.2% |
| Bipolar Disorder |
0.1% |
| Blood Cholesterol Increased |
0.1% |
| Dyspnoea |
0.1% |
| Oral Infection |
0.1% |
| Hypothyroidism |
0.1% |
| Inflammation |
0.1% |
|
| Pharmaceutical Product Complaint |
28.5% |
| Death |
14.1% |
| Dysphonia |
9.0% |
| Drug Ineffective |
6.5% |
| Product Quality Issue |
4.6% |
| Wheezing |
4.6% |
| Weight Increased |
4.4% |
| Dyspnoea |
3.3% |
| Asthma |
3.1% |
| Pneumonia |
2.7% |
| Tremor |
2.4% |
| Muscle Spasms |
2.3% |
| Pharyngolaryngeal Pain |
2.3% |
| Oral Candidiasis |
2.1% |
| Throat Irritation |
2.1% |
| Status Asthmaticus |
2.0% |
| Cough |
1.6% |
| Rash |
1.6% |
| Vomiting |
1.6% |
| Respiratory Failure |
1.3% |
|
| Secondary |
| Asthma |
28.5% |
| Chronic Obstructive Pulmonary Disease |
15.1% |
| Drug Use For Unknown Indication |
9.6% |
| Emphysema |
8.7% |
| Bronchitis |
5.3% |
| Dyspepsia |
4.4% |
| Hypertension |
3.9% |
| Depression |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Dyspnoea |
2.2% |
| Migraine |
2.1% |
| Epilepsy |
1.9% |
| Fungal Infection |
1.8% |
| Hysterectomy |
1.8% |
| Antiplatelet Therapy |
1.7% |
| Seasonal Affective Disorder |
1.7% |
| Blood Cholesterol Increased |
1.5% |
| Fibromyalgia |
1.5% |
| Blood Testosterone Abnormal |
1.3% |
| Onychomycosis |
1.3% |
|
| Swelling Face |
9.8% |
| Product Quality Issue |
8.0% |
| Weight Decreased |
7.1% |
| Weight Increased |
7.1% |
| Tremor |
6.3% |
| Chronic Obstructive Pulmonary Disease |
5.4% |
| Pneumonia |
5.4% |
| Sinusitis |
5.4% |
| Drug Ineffective |
4.5% |
| Pharmaceutical Product Complaint |
4.5% |
| Productive Cough |
4.5% |
| Throat Irritation |
4.5% |
| Urinary Tract Infection |
4.5% |
| Vision Blurred |
4.5% |
| Wheezing |
4.5% |
| Candidiasis |
3.6% |
| Death |
2.7% |
| Dry Mouth |
2.7% |
| Dysphonia |
2.7% |
| Nausea |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
36.1% |
| Asthma |
13.7% |
| Chronic Obstructive Pulmonary Disease |
11.3% |
| Product Used For Unknown Indication |
6.0% |
| Hypertension |
4.7% |
| Hypersensitivity |
3.2% |
| Depression |
2.9% |
| Pain |
2.4% |
| Dyspnoea |
2.4% |
| Emphysema |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Osteoporosis |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Diabetes Mellitus |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Anxiety |
1.6% |
| Non-small Cell Lung Cancer |
1.4% |
| Prophylaxis |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Pulmonary Arterial Hypertension |
1.1% |
|
| Dyspnoea |
11.3% |
| Vomiting |
9.7% |
| Pneumonia |
7.6% |
| Weight Decreased |
7.0% |
| Death |
5.5% |
| Weight Increased |
5.3% |
| Wheezing |
5.2% |
| Drug Ineffective |
5.0% |
| Urticaria |
4.6% |
| Type 2 Diabetes Mellitus |
4.5% |
| Urinary Tract Infection |
4.1% |
| Myocardial Infarction |
4.0% |
| Vision Blurred |
3.8% |
| Nausea |
3.7% |
| Pain |
3.4% |
| Suicidal Ideation |
3.3% |
| Rash |
3.2% |
| Tremor |
3.1% |
| Pruritus |
2.9% |
| Flushing |
2.8% |
|
| Interacting |
| Asthma |
16.7% |
| Chronic Obstructive Pulmonary Disease |
16.7% |
| Emphysema |
16.7% |
| Smoking Cessation Therapy |
16.7% |
| Gastrooesophageal Reflux Disease |
11.1% |
| Barrett's Oesophagus |
5.6% |
| Bronchitis |
5.6% |
| Ex-tobacco User |
5.6% |
| Headache |
5.6% |
|
| Weight Increased |
42.9% |
| Drug Interaction |
14.3% |
| Dyspnoea |
14.3% |
| Nausea |
14.3% |
| Wheezing |
14.3% |
|
